WO2001044266A3 - Nucleic acid compounds and screening assays using the same - Google Patents
Nucleic acid compounds and screening assays using the same Download PDFInfo
- Publication number
- WO2001044266A3 WO2001044266A3 PCT/GB2000/004862 GB0004862W WO0144266A3 WO 2001044266 A3 WO2001044266 A3 WO 2001044266A3 GB 0004862 W GB0004862 W GB 0004862W WO 0144266 A3 WO0144266 A3 WO 0144266A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- same
- acid compounds
- screening assays
- nucleotides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00985610A EP1237899A2 (en) | 1999-12-16 | 2000-12-18 | Nucleic acid compounds and screening assays using the same |
AU22018/01A AU2201801A (en) | 1999-12-16 | 2000-12-18 | Assays |
CA002391814A CA2391814A1 (en) | 1999-12-16 | 2000-12-18 | Assays |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9929820.0A GB9929820D0 (en) | 1999-12-16 | 1999-12-16 | Assay |
GB9929820.0 | 1999-12-16 | ||
US17180499P | 1999-12-22 | 1999-12-22 | |
US60/171,804 | 1999-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001044266A2 WO2001044266A2 (en) | 2001-06-21 |
WO2001044266A3 true WO2001044266A3 (en) | 2001-12-20 |
Family
ID=26316129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/004862 WO2001044266A2 (en) | 1999-12-16 | 2000-12-18 | Nucleic acid compounds and screening assays using the same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1237899A2 (en) |
AU (1) | AU2201801A (en) |
CA (1) | CA2391814A1 (en) |
WO (1) | WO2001044266A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11851449B2 (en) | 2013-07-03 | 2023-12-26 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compounds having an RORvt inhibitory action |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027383A1 (en) * | 2000-06-02 | 2001-12-20 | Rhein Biotech Proz & Prod Gmbh | Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide |
WO2003018747A2 (en) * | 2001-08-22 | 2003-03-06 | Isis Pharmaceuticals, Inc. | Molecular interaction sites of hepatitis c virus rna and methods of modulating the same |
FR2848572B1 (en) * | 2002-12-12 | 2005-12-09 | Univ Joseph Fourier | INHIBITOR MOLECULES OF PROTEIN SYNTHESIS OF HEPATITIS C VIRUS AND METHOD FOR SCREENING THESE INHIBITORY MOLECULES |
WO2004078974A1 (en) * | 2003-01-24 | 2004-09-16 | Tokyo Metropolitan Organization For Medical Research | Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
GB0302113D0 (en) * | 2003-01-29 | 2003-03-05 | Medical Res Council | Ires |
FR2974805B1 (en) | 2011-05-02 | 2013-05-10 | Isp Investments Inc | NOVEL MODULATING PEPTIDES OF THE TRF-2 PROTEIN AND COMPOSITIONS COMPRISING THEM |
EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
US10053468B2 (en) | 2013-07-03 | 2018-08-21 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997009342A1 (en) * | 1995-09-08 | 1997-03-13 | Scriptgen Pharmaceuticals, Inc. | Screen for compounds with affinity for rna |
US5922857A (en) * | 1992-09-28 | 1999-07-13 | Chiron Corporation | Methods and compositions for controlling translation of HCV proteins |
-
2000
- 2000-12-18 WO PCT/GB2000/004862 patent/WO2001044266A2/en not_active Application Discontinuation
- 2000-12-18 EP EP00985610A patent/EP1237899A2/en not_active Withdrawn
- 2000-12-18 AU AU22018/01A patent/AU2201801A/en not_active Abandoned
- 2000-12-18 CA CA002391814A patent/CA2391814A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922857A (en) * | 1992-09-28 | 1999-07-13 | Chiron Corporation | Methods and compositions for controlling translation of HCV proteins |
WO1997009342A1 (en) * | 1995-09-08 | 1997-03-13 | Scriptgen Pharmaceuticals, Inc. | Screen for compounds with affinity for rna |
Non-Patent Citations (4)
Title |
---|
DATABASE EMBL EBI; 30 October 1998 (1998-10-30), MICHALEK ET AL.: "Hordeum vulgare genomic DNA fragment; clone MWG0065.rev", XP002178313 * |
SIZOVA ET AL.: "Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis c virus and classical swine fever virus RNAs", JOURNAL OF VIROLOGY, vol. 72, no. 6, June 1998 (1998-06-01), pages 4775 - 4782, XP000993423 * |
WALLIS ET AL.: "In vitro selection of a viomycin-binding RNA pseudoknot", CHEMISTRY AND BIOLOGY, vol. 4, no. 5, 1997, pages 357 - 366, XP001024489 * |
WANG Y ET AL: "Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 36, 1997, pages 768 - 779, XP002120808, ISSN: 0006-2960 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11851449B2 (en) | 2013-07-03 | 2023-12-26 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compounds having an RORvt inhibitory action |
Also Published As
Publication number | Publication date |
---|---|
EP1237899A2 (en) | 2002-09-11 |
WO2001044266A2 (en) | 2001-06-21 |
AU2201801A (en) | 2001-06-25 |
CA2391814A1 (en) | 2001-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268513A1 (en) | Nucleic acid accessible hybridization sites | |
AU2001273548A1 (en) | Photoselection of nucleic acid ligands | |
CA2283509A1 (en) | Novel bicyclonucleoside and oligonucleotide analogue | |
AU4332399A (en) | Rna polymerase chain reaction | |
WO2000040525A3 (en) | Polymer arrays and methods of making and using same | |
AU2002365811A1 (en) | Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations | |
WO2003052110A3 (en) | Nucleic acid nematicides | |
AU2001278061A1 (en) | Triphosphate oligonucleotide modification reagents and uses thereof | |
AU2001275192A1 (en) | Determination of nucleotide sequence variations through limited primer extension | |
CA2438574A1 (en) | Method of detecting nucleotide polymorphism | |
AU2001241674A1 (en) | Variant galactose oxidase, nucleic acid encoding same, and methods of using same | |
WO2001044266A3 (en) | Nucleic acid compounds and screening assays using the same | |
IL136349A0 (en) | Virulence-associated nucleic acid sequences and uses thereof | |
AU2002352902A1 (en) | Thermus thermophilus nucleic acid polymerases | |
AU2002346517A1 (en) | Thermus oshimai nucleic acid polymerases | |
DE69833112D1 (en) | Rna polymerase | |
AU1981295A (en) | Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto | |
EP0622464A3 (en) | Nucleic acid assay procedure. | |
EP1300473A4 (en) | Method of detecting nucleotide polymorphism | |
EP1090997A4 (en) | Hcv-derived rna polymerase gene | |
GB9920049D0 (en) | Thermostable dna polymerase | |
AU2001251245A1 (en) | Haplotypes of the apoa4 gene | |
AU2002219230A1 (en) | Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications | |
AU2002350247A1 (en) | Thermus igniterrae nucleic acid polymerases | |
AU2001280727A1 (en) | Haplotypes of the adrb3 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2391814 Country of ref document: CA Ref document number: 22018/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000985610 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000985610 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000985610 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |